Intratumoral Neoadjuvant Immunotherapy Using IL-12 and Dendritic Cells Is an Effective Strategy To Control Recurrence of Murine Hepatocellular Carcinoma in Immunosuppressed Mice-Reference-Cited by-同舟云学术

Intratumoral Neoadjuvant Immunotherapy Using IL-12 and Dendritic Cells Is an Effective Strategy To Control Recurrence of Murine Hepatocellular Carcinoma in Immunosuppressed Mice

Published:2010-05-24 Issue:1 Volume:185 Page:698-708
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J.I.

Author:

Kayashima Hiroto,Toshima Takeo,Okano Shinji,Taketomi Akinobu,Harada Noboru,Yamashita Yo-ichi,Tomita Yukihiro,Shirabe Ken,Maehara Yoshihiko

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference71 articles.

1. Immunotherapy: past, present and future

2. Cancer immunotherapy: moving beyond current vaccines

3. Immunosuppressive networks in the tumour environment and their therapeutic relevance

4. Tumor-Driven Evolution of Immunosuppressive Networks during Malignant Progression

5. Mechanisms and functional significance of tumour-induced dendritic-cell defects

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. When immunotherapy meets liver transplantation for hepatocellular carcinoma: A bumpy but promising road;Chinese Journal of Cancer Research;2023

2. Research Progress on the Mechanism of Action of the Active Ingredient of Rhizoma Smilacis Glabrae in the Treatment of Psoriasis;Traditional Chinese Medicine;2023

3. The novel immune-related genes predict the prognosis of patients with hepatocellular carcinoma;Scientific Reports;2021-05-21

4. Natural Killer–Dendritic Cell Interactions in Liver Cancer: Implications for Immunotherapy;Cancers;2021-05-01

5. Cell Therapy for Liver Disease: From Promise to Reality;Seminars in Liver Disease;2020-11